top of page
New Logo_edited.png
ChatGPT Image Jun 25, 2026, 01_45_49 PM.png
Search

PAY TO PLAY REFERRALS AO 26-15

  • Lisa Stanton
  • Jul 1
  • 2 min read

Pay-to-Play Referrals? OIG Draws a Hard Line on Referral Technology

Healthcare Compliance Alert | OIG Advisory Opinion 26-15

The Office of Inspector General (OIG) recently issued an unfavorable advisory opinion that sends a clear message to healthcare providers: Paying for faster access to patient referrals can create serious Anti-Kickback Statute (AKS) risk. 

What Happened?

A home health agency paid a subscription fee to use an online referral management platform that allowed hospitals to send and receive patient referrals electronically. While all qualified agencies appeared on the hospital's referral list, only agencies that paid for the software could receive and accept referrals instantly. Non-paying providers had to rely on slower methods like fax, email, or phone calls.

Why Did OIG Say "No"?

The OIG determined that this arrangement could violate the Federal Anti-Kickback Statute because paying for access to the platform effectively paid for a competitive advantage in receiving referrals. The agency was concerned that:

  • Speed—not quality of care—could determine who receives patients. 

  • Smaller providers that cannot afford subscription fees may be unfairly excluded.

  • Providers may feel pressure to increase utilization simply to recover the cost of participation.

  • The arrangement did not qualify for a regulatory "safe harbor" designed to protect legitimate referral services.

The Biggest Takeaway

This opinion isn't really about software.

It's about whether technology creates an unfair pathway to federally reimbursed patient referrals. If paying for a platform gives one provider a referral advantage over another, regulators may view that payment as prohibited remuneration under the Anti-Kickback Statute.

What Providers Should Do

Healthcare organizations should ask:

✔️ Does this technology improve workflow—or does it influence referrals?

✔️ Are fees based on the actual cost of the service, or are they effectively buying faster access to patients?

✔️ Has legal and compliance reviewed the arrangement before signing the contract?

KLS Compliance Perspective

As healthcare becomes increasingly digital, compliance risks are evolving just as quickly. Innovative technology is valuable—but only when it promotes patient choice, fair competition, and regulatory compliance.

Technology should improve patient care—not become a shortcut to patient referrals.

Source: HHS Office of Inspector General, Advisory Opinion No. 26-15 (Issued June 25, 2026; Posted June 30, 2026). 


 
 
 

Comments


bottom of page